Related Articles
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis
Elimination of CD4+ T cells may overcome suppression of anti-HER2 immune responses in tumor-bearing hosts
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer
Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination